{"entity":{"type":"insider","cik":"0001397144","url":"/insider/0001397144","json_url":"/insider/0001397144.json","name":"Abingworth LLP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":35,"n_filings":25,"first":"2011-03-02","last":"2024-02-12","span_basis":"filed_date"},"name_variants":[{"name":"Abingworth LLP","source":"filing","n_filings":25,"first_seen":"2011-03-02","last_seen":"2024-02-12"}],"transactions":[{"id":2386477,"accession":"0000950170-24-014017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-014017","line_url":"/filing/0000950170-24-014017#line-1","is_derivative":false,"issuer_cik":"0000933790","issuer_name":"Jasper Therapeutics, Inc.","issuer_ticker":"JSPR","issuer_name_source":null,"issuer_url":"/issuer/0000933790","owner_cik":null,"owner_name":"Abingworth Bioventures VII LP; Abingworth LLP; CG Subsidiary Holdings L.L.C.; Carlyle Genesis UK LLC; Carlyle Group Inc.; Carlyle Holdings I GP Inc.; Carlyle Holdings I GP Sub L.L.C.; Carlyle Holdings I L.P.; Carlyle Investment Management LLC; TC Group, LLC","owner_display_name":"Abingworth Bioventures VII LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":190000.0,"shares_display":"190,000","price_per_share":12.95,"price_display":"12.95","price_state":"stated","total_value":2460500.0,"total_display":"2,460,500.00","total_whole":"2,460,500","shares_owned_after":1066189.0,"shares_owned_after_display":"1,066,189","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-08","filed_date":"2024-02-12","scope":"insider"},{"id":8135071,"accession":"0000899243-23-003059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-003059","line_url":"/filing/0000899243-23-003059#line-1","is_derivative":false,"issuer_cik":"0000933790","issuer_name":"Jasper Therapeutics, Inc.","issuer_ticker":"JSPR","issuer_name_source":null,"issuer_url":"/issuer/0000933790","owner_cik":null,"owner_name":"Carlyle Holdings I GP Sub L.L.C.; Carlyle Holdings I L.P.; TC Group, LLC; Carlyle Investment Management LLC; Abingworth LLP; Carlyle Group Inc.; CG Subsidiary Holdings L.L.C.; Carlyle Genesis UK LLC; Carlyle Holdings I GP Inc.","owner_display_name":"Carlyle Holdings I GP Sub L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3133333.0,"shares_display":"3,133,333","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":4699999.5,"total_display":"4,699,999.50","total_whole":"4,700,000","shares_owned_after":8761891.0,"shares_owned_after_display":"8,761,891","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-31","scope":"insider"},{"id":6318868,"accession":"0000899243-22-029282","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-029282","line_url":"/filing/0000899243-22-029282","is_derivative":false,"issuer_cik":"0000933790","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0000933790","owner_cik":null,"owner_name":"Carlyle Group Inc.; Carlyle Holdings I GP Inc.; CG Subsidiary Holdings L.L.C.; Carlyle Investment Management LLC; Carlyle Holdings I L.P.; Carlyle Genesis UK LLC; TC Group, LLC; Carlyle Holdings I GP Sub L.L.C.; Abingworth Bioventures 8 LP; Abingworth LLP","owner_display_name":"Carlyle Group Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9925.0,"shares_display":"9,925","price_per_share":20.25451986901763,"price_display":"20.25","price_state":"stated","total_value":201026.1097,"total_display":"201,026.11","total_whole":"201,026","shares_owned_after":2960403.0,"shares_owned_after_display":"2,960,403","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-19","scope":"insider","n_lines":3},{"id":6365020,"accession":"0000905718-22-000523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-22-000523","line_url":"/filing/0000905718-22-000523#line-1","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7720000.0,"shares_display":"7,720,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":18022602.0,"shares_owned_after_display":"18,022,602","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-29","filed_date":"2022-03-31","scope":"insider"},{"id":6981938,"accession":"0000905718-22-000177","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-22-000177","line_url":"/filing/0000905718-22-000177#line-2","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":4050000.0,"total_display":"4,050,000.00","total_whole":"4,050,000","shares_owned_after":1314127.0,"shares_owned_after_display":"1,314,127","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-31","filed_date":"2022-02-01","scope":"insider"},{"id":4605894,"accession":"0000905718-21-000712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-21-000712","line_url":"/filing/0000905718-21-000712#line-2","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":772727.0,"shares_display":"772,727","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":8499997.0,"total_display":"8,499,997.00","total_whole":"8,499,997","shares_owned_after":2960231.0,"shares_owned_after_display":"2,960,231","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-18","scope":"insider"},{"id":3320560,"accession":"0000905718-20-001059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-20-001059","line_url":"/filing/0000905718-20-001059#line-1","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"Personalis, Inc.","issuer_ticker":"PSNL","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":130486.0,"shares_display":"130,486","price_per_share":27.66,"price_display":"27.66","price_state":"stated","total_value":3609242.76,"total_display":"3,609,242.76","total_whole":"3,609,243","shares_owned_after":3753340.0,"shares_owned_after_display":"3,753,340","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-20","filed_date":"2020-10-21","scope":"insider"},{"id":2420031,"accession":"0000905718-20-001057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-20-001057","line_url":"/filing/0000905718-20-001057#line-2","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"Personalis, Inc.","issuer_ticker":"PSNL","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":196423.0,"shares_display":"196,423","price_per_share":27.86,"price_display":"27.86","price_state":"stated","total_value":5472344.78,"total_display":"5,472,344.78","total_whole":"5,472,345","shares_owned_after":3883826.0,"shares_owned_after_display":"3,883,826","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-19","filed_date":"2020-10-20","scope":"insider"},{"id":2420027,"accession":"0000905718-20-001057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-20-001057","line_url":"/filing/0000905718-20-001057#line-1","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"Personalis, Inc.","issuer_ticker":"PSNL","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94218.0,"shares_display":"94,218","price_per_share":26.68,"price_display":"26.68","price_state":"stated","total_value":2513736.24,"total_display":"2,513,736.24","total_whole":"2,513,736","shares_owned_after":4080249.0,"shares_owned_after_display":"4,080,249","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-16","filed_date":"2020-10-20","scope":"insider"},{"id":2908367,"accession":"0000905718-20-001051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-20-001051","line_url":"/filing/0000905718-20-001051#line-2","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"Personalis, Inc.","issuer_ticker":"PSNL","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":26.32,"price_display":"26.32","price_state":"stated","total_value":97384.0,"total_display":"97,384.00","total_whole":"97,384","shares_owned_after":4174467.0,"shares_owned_after_display":"4,174,467","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-15","filed_date":"2020-10-16","scope":"insider"},{"id":2908364,"accession":"0000905718-20-001051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-20-001051","line_url":"/filing/0000905718-20-001051#line-1","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"Personalis, Inc.","issuer_ticker":"PSNL","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81925.0,"shares_display":"81,925","price_per_share":27.08,"price_display":"27.08","price_state":"stated","total_value":2218529.0,"total_display":"2,218,529.00","total_whole":"2,218,529","shares_owned_after":4178167.0,"shares_owned_after_display":"4,178,167","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-16","scope":"insider"},{"id":2514052,"accession":"0000905718-20-001041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-20-001041","line_url":"/filing/0000905718-20-001041#line-2","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"Personalis, Inc.","issuer_ticker":"PSNL","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86819.0,"shares_display":"86,819","price_per_share":28.43,"price_display":"28.43","price_state":"stated","total_value":2468264.17,"total_display":"2,468,264.17","total_whole":"2,468,264","shares_owned_after":4260092.0,"shares_owned_after_display":"4,260,092","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-13","filed_date":"2020-10-14","scope":"insider"},{"id":2514045,"accession":"0000905718-20-001041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-20-001041","line_url":"/filing/0000905718-20-001041#line-1","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"Personalis, Inc.","issuer_ticker":"PSNL","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115541.0,"shares_display":"115,541","price_per_share":29.09,"price_display":"29.09","price_state":"stated","total_value":3361087.69,"total_display":"3,361,087.69","total_whole":"3,361,088","shares_owned_after":4346911.0,"shares_owned_after_display":"4,346,911","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-12","filed_date":"2020-10-14","scope":"insider"},{"id":2634358,"accession":"0000905718-20-000875","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-20-000875","line_url":"/filing/0000905718-20-000875#line-1","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"Personalis, Inc.","issuer_ticker":"PSNL","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":986842.0,"shares_display":"986,842","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":18749998.0,"total_display":"18,749,998.00","total_whole":"18,749,998","shares_owned_after":4462452.0,"shares_owned_after_display":"4,462,452","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":2209187,"accession":"0000905718-20-000722","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-20-000722","line_url":"/filing/0000905718-20-000722#line-1","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3333330.0,"shares_display":"3,333,330","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":5499994.5,"total_display":"5,499,994.50","total_whole":"5,499,995","shares_owned_after":10302602.0,"shares_owned_after_display":"10,302,602","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-26","filed_date":"2020-07-06","scope":"insider"},{"id":8507854,"accession":"0000905718-19-000873","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-19-000873","line_url":"/filing/0000905718-19-000873#line-1","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2300000.0,"shares_display":"2,300,000","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":2760000.0,"total_display":"2,760,000.00","total_whole":"2,760,000","shares_owned_after":6969272.0,"shares_owned_after_display":"6,969,272","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-25","filed_date":"2019-10-29","scope":"insider"},{"id":6721455,"accession":"0000905718-18-000472","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000472","line_url":"/filing/0000905718-18-000472#line-1","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"Sientra, Inc.","issuer_ticker":"SIEN","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":281482.0,"shares_display":"281,482","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":3800007.0,"total_display":"3,800,007.00","total_whole":"3,800,007","shares_owned_after":2480494.0,"shares_owned_after_display":"2,480,494","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-07","filed_date":"2018-05-09","scope":"insider"},{"id":6690723,"accession":"0000905718-14-000723","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-14-000723","line_url":"/filing/0000905718-14-000723#line-1","is_derivative":false,"issuer_cik":"0001397144","issuer_name":"Sientra, Inc.","issuer_ticker":"SIEN","issuer_name_source":null,"issuer_url":"/issuer/0001397144","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":495000.0,"shares_display":"495,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":7425000.0,"total_display":"7,425,000.00","total_whole":"7,425,000","shares_owned_after":2199012.0,"shares_owned_after_display":"2,199,012","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-29","filed_date":"2014-10-31","scope":"insider"},{"id":6984216,"accession":"0000905718-14-000703","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-14-000703","line_url":"/filing/0000905718-14-000703#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"PROTEON THERAPEUTICS INC","issuer_ticker":"PRTO","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":950000.0,"shares_display":"950,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":9500000.0,"total_display":"9,500,000.00","total_whole":"9,500,000","shares_owned_after":950000.0,"shares_owned_after_display":"950,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-27","filed_date":"2014-10-29","scope":"insider"},{"id":9232026,"accession":"0001140361-12-021579","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-12-021579","line_url":"/filing/0001140361-12-021579#line-3","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":682000.0,"shares_display":"682,000","price_per_share":9.6574,"price_display":"9.66","price_state":"stated","total_value":6586346.8,"total_display":"6,586,346.80","total_whole":"6,586,347","shares_owned_after":1599168.0,"shares_owned_after_display":"1,599,168","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-19","filed_date":"2012-04-26","scope":"insider"},{"id":2295311,"accession":"0001144204-12-022786","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-12-022786","line_url":"/filing/0001144204-12-022786#line-3","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":682000.0,"shares_display":"682,000","price_per_share":9.6574,"price_display":"9.66","price_state":"stated","total_value":6586346.8,"total_display":"6,586,346.80","total_whole":"6,586,347","shares_owned_after":1599168.0,"shares_owned_after_display":"1,599,168","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-19","filed_date":"2012-04-19","scope":"insider"},{"id":9232028,"accession":"0001140361-12-021579","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-12-021579","line_url":"/filing/0001140361-12-021579#line-2","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1614341.0,"shares_display":"1,614,341","price_per_share":9.6049,"price_display":"9.60","price_state":"stated","total_value":15505583.8709,"total_display":"15,505,583.87","total_whole":"15,505,584","shares_owned_after":2281168.0,"shares_owned_after_display":"2,281,168","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-18","filed_date":"2012-04-26","scope":"insider"},{"id":2295308,"accession":"0001144204-12-022786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-12-022786","line_url":"/filing/0001144204-12-022786#line-2","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1614341.0,"shares_display":"1,614,341","price_per_share":9.6049,"price_display":"9.60","price_state":"stated","total_value":15505583.8709,"total_display":"15,505,583.87","total_whole":"15,505,584","shares_owned_after":2281168.0,"shares_owned_after_display":"2,281,168","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-18","filed_date":"2012-04-19","scope":"insider"},{"id":9232027,"accession":"0001140361-12-021579","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-021579","line_url":"/filing/0001140361-12-021579#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1712000.0,"shares_display":"1,712,000","price_per_share":9.6111,"price_display":"9.61","price_state":"stated","total_value":16454203.2,"total_display":"16,454,203.20","total_whole":"16,454,203","shares_owned_after":3895509.0,"shares_owned_after_display":"3,895,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-17","filed_date":"2012-04-26","scope":"insider"},{"id":2295303,"accession":"0001144204-12-022786","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-022786","line_url":"/filing/0001144204-12-022786#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1712000.0,"shares_display":"1,712,000","price_per_share":9.6111,"price_display":"9.61","price_state":"stated","total_value":16454203.2,"total_display":"16,454,203.20","total_whole":"16,454,203","shares_owned_after":3895509.0,"shares_owned_after_display":"3,895,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-17","filed_date":"2012-04-19","scope":"insider"},{"id":3119734,"accession":"0001140361-12-019608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-019608","line_url":"/filing/0001140361-12-019608#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300000.0,"shares_display":"2,300,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":25300000.0,"total_display":"25,300,000.00","total_whole":"25,300,000","shares_owned_after":5607509.0,"shares_owned_after_display":"5,607,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-03","filed_date":"2012-04-05","scope":"insider"},{"id":8831953,"accession":"0001140361-11-022726","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-11-022726","line_url":"/filing/0001140361-11-022726#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4179174.0,"shares_display":"4,179,174","price_per_share":14.8698,"price_display":"14.87","price_state":"stated","total_value":62143481.5452,"total_display":"62,143,481.55","total_whole":"62,143,482","shares_owned_after":7895826.0,"shares_owned_after_display":"7,895,826","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-04-18","filed_date":"2011-04-20","scope":"insider"},{"id":8959109,"accession":"0001140361-11-016696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-11-016696","line_url":"/filing/0001140361-11-016696#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2750000.0,"shares_display":"2,750,000","price_per_share":7.504,"price_display":"7.50","price_state":"stated","total_value":20636000.0,"total_display":"20,636,000.00","total_whole":"20,636,000","shares_owned_after":12075000.0,"shares_owned_after_display":"12,075,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-11","filed_date":"2011-03-15","scope":"insider"},{"id":8851104,"accession":"0001140361-11-015754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-11-015754","line_url":"/filing/0001140361-11-015754#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":550000.0,"shares_display":"550,000","price_per_share":7.5018,"price_display":"7.50","price_state":"stated","total_value":4125990.0,"total_display":"4,125,990.00","total_whole":"4,125,990","shares_owned_after":14825000.0,"shares_owned_after_display":"14,825,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-08","filed_date":"2011-03-10","scope":"insider"},{"id":9090153,"accession":"0001140361-11-015160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-11-015160","line_url":"/filing/0001140361-11-015160#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":7.6,"price_display":"7.60","price_state":"stated","total_value":760000.0,"total_display":"760,000.00","total_whole":"760,000","shares_owned_after":15375000.0,"shares_owned_after_display":"15,375,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-04","filed_date":"2011-03-08","scope":"insider"},{"id":8851063,"accession":"0001140361-11-014276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-11-014276","line_url":"/filing/0001140361-11-014276#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200000.0,"shares_display":"1,200,000","price_per_share":7.6992,"price_display":"7.70","price_state":"stated","total_value":9239040.0,"total_display":"9,239,040.00","total_whole":"9,239,040","shares_owned_after":15475000.0,"shares_owned_after_display":"15,475,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-02","filed_date":"2011-03-04","scope":"insider"},{"id":9151531,"accession":"0001140361-11-013380","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-11-013380","line_url":"/filing/0001140361-11-013380#line-2","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":7.6097,"price_display":"7.61","price_state":"stated","total_value":380485.0,"total_display":"380,485.00","total_whole":"380,485","shares_owned_after":16675000.0,"shares_owned_after_display":"16,675,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-01","filed_date":"2011-03-02","scope":"insider"},{"id":9151530,"accession":"0001140361-11-013380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-11-013380","line_url":"/filing/0001140361-11-013380#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":"0001397144","owner_name":"Abingworth LLP","owner_display_name":"Abingworth LLP","owner_url":"/insider/0001397144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, 50 pence par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":275000.0,"shares_display":"275,000","price_per_share":7.9205,"price_display":"7.92","price_state":"stated","total_value":2178137.5,"total_display":"2,178,137.50","total_whole":"2,178,138","shares_owned_after":16725000.0,"shares_owned_after_display":"16,725,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-28","filed_date":"2011-03-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001788028","name":"Jasper Therapeutics, Inc.","url":"/issuer/0001788028","role":"Ten percent owner","n_filings":2,"first_seen":"2023-01-31","last_seen":"2024-02-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001831828","name":"Vera Therapeutics, Inc.","url":"/issuer/0001831828","role":"Ten percent owner","n_filings":2,"first_seen":"2021-05-18","last_seen":"2022-08-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001484565","name":"SOLENO THERAPEUTICS INC","url":"/issuer/0001484565","role":"Ten percent owner","n_filings":3,"first_seen":"2019-10-29","last_seen":"2022-03-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001290149","name":"Sierra Oncology, Inc.","url":"/issuer/0001290149","role":"Ten percent owner","n_filings":1,"first_seen":"2022-02-01","last_seen":"2022-02-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001527753","name":"Personalis, Inc.","url":"/issuer/0001527753","role":"Ten percent owner, Other","n_filings":5,"first_seen":"2020-08-20","last_seen":"2020-10-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001551693","name":"Sientra, Inc.","url":"/issuer/0001551693","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2014-10-31","last_seen":"2018-05-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001359931","name":"PROTEON THERAPEUTICS INC","url":"/issuer/0001359931","role":"Ten percent owner","n_filings":1,"first_seen":"2014-10-29","last_seen":"2014-10-29"},{"type":"issuer","type_label":"ISSUER","cik":"0000897448","name":"AMARIN CORP PLC\\UK","url":"/issuer/0000897448","role":"Ten percent owner","n_filings":9,"first_seen":"2011-03-02","last_seen":"2012-04-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001397144","retrieved_at":"2026-08-23T19:42:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}